Literature DB >> 25675330

Heart Failure Models: Traditional and Novel Therapy.

Mohamed A Haidara1, Abdullah S Assiri, Hanaa Z Yassin, Hania I Ammar, Milan M Obradovic, Esma R Isenovic.   

Abstract

Cardiovascular disease (CVD) is among the most major causes of morbidity and mortality worldwide. Great progress has been made in the management of CVD which has been influenced by the use of experimental animal models. These models provided information at cellular and molecular levels and allowed the development of treatment strategies. CVD models have been developed in many species, including large animals (e.g. pigs and dogs) and small animals (e.g. rats and mice). Although, no model can solely reproduce clinical HF, simulations of heart failure (HF) are available to experimentally tackle certain queries not easily resolved in humans. Induced HF may also be produced experimentally through myocardial infarction (MI), pressure loading, or volume loading. Volume loading is useful to look at hormone and electrolyte disturbances, while pressure loading models is helpful to study ventricular hypertrophy, cellular imbalance and vascular changes in HF. Coronary heart disease is assessed in MI animal models. In this review we describe various experimental models used to study the pathophysiology of HF.

Entities:  

Mesh:

Year:  2015        PMID: 25675330     DOI: 10.2174/1570161113666150212151506

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  6 in total

Review 1.  Defining the Cardiac Fibroblast.

Authors:  Malina J Ivey; Michelle D Tallquist
Journal:  Circ J       Date:  2016-10-14       Impact factor: 2.993

2.  Isolation and Culture of Primary Endothelial Cells from Canine Arteries and Veins.

Authors:  Loes A Oosterhoff; Hedwig S Kruitwagen; Bart Spee; Frank G van Steenbeek
Journal:  J Vis Exp       Date:  2016-11-18       Impact factor: 1.355

3.  The experimental model of transition from compensated cardiac hypertrophy to failure created by transverse aortic constriction in mice.

Authors:  Takaaki Furihata; Shintaro Kinugawa; Shingo Takada; Arata Fukushima; Masashige Takahashi; Tsuneaki Homma; Yoshihiro Masaki; Masaya Tsuda; Junichi Matsumoto; Wataru Mizushima; Shouji Matsushima; Takashi Yokota; Hiroyuki Tsutsui
Journal:  Int J Cardiol Heart Vasc       Date:  2016-03-16

4.  Pharmacodynamic Evaluation of Shenfu Injection in Rats With Ischemic Heart Failure and Its Effect on Small Molecules Using Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging.

Authors:  Hao Wu; Zhenfeng Dai; Xi Liu; Ming Lin; Zeyu Gao; Fang Tian; Xin Zhao; Yi Sun; Xiaoping Pu
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

5.  Intermittent Short-Duration Re-oxygenation Attenuates Cardiac Changes in Response to Hypoxia: Histological, Ultrastructural and Oxidant/Antioxidant Parameters.

Authors:  Ayed A Shati; Mohamed Samir A Zaki; Youssef A Alqahtani; Mohamed A Haidara; Mohammed A Alshehri; Amal F Dawood; Refaat A Eid
Journal:  Br J Biomed Sci       Date:  2022-03-18       Impact factor: 2.432

6.  Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats.

Authors:  Yunshan Cao; Jiyang Song; Shutong Shen; Heling Fu; Xiang Li; Ying Xu; Aqian Wang; Xinli Li; Min Zhang
Journal:  Oncotarget       Date:  2017-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.